The largest database of trusted experimental protocols

Halo ai

Manufactured by Indica Labs
Sourced in United States

HALO® AI is an advanced digital pathology platform developed by Indica Labs. It provides an automated image analysis solution for quantifying histological features in whole slide images. The core function of HALO® AI is to enable efficient and accurate analysis of digital pathology samples.

Automatically generated - may contain errors

Lab products found in correlation

7 protocols using halo ai

1

Multiplex IHC Analysis of Bladder Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Digital slide review and quality control assessment were performed by a board-certified pathologist (R.B). Regions of tissues defined by folds and staining artefacts were excluded from analyses. HALO™ digital imaging analysis platform was used for quantitative tissue analysis (Indica Labs, Inc.), using Halo AI™ for train-by-example classification and segmentation followed by random forest algorithm classifier, multiplex IHC module and color deconvolution to separate chromogenic stains to prepare for quantitative analysis. Briefly, bladder tumor sections were classified into features defined by cell lineages: tumors, stroma, and immune cells as well as glass exposed through torn tissue, which was excluded from subsequent semi-automated analyses. The numbers of individual tumor, stromal and immune cells staining negative or positive for all antibodies were enumerated in each region of interest (ROI) analyzed. Positively staining tumor cells were stratified as tertiles (dim, moderate, and bright). External control tissues derived from human tonsil were used to calibrate staining intensity detection limits. For each tissue section, a minimum of five ROIs were analyzed and the total surface area (mm2) was recorded.
+ Open protocol
+ Expand
2

Automated Tissue Classification in BCG-Treated Tumor Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
To classify tumor tissue into ‘stroma’, ‘epithelium’, and ‘artifacts’ compartments (Figure 2), we trained the HALO® AI (Indica Labs, Albuquerque, NM, USA) Densenet v2 classifier using manual annotations provided by the pathologist (JD) in BCG-treated patient cohort. The annotations were created using a built-in HALO® AI annotation tool via the user-friendly graphical user interface. The image data within the annotated regions are automatically incorporated into the model training pipeline through HALO® AI’s native methods, eliminating the need for manual data management. The ‘artifacts’ class was incorporated to exclude areas of coagulation, necrosis, hemorrhage, or calcifications that could potentially interfere with further analyses. The quality of tissue classification masks produced by HALO® AI was visually assessed by a pathologist (JD). Following initial tissue classification and artifact exclusion, due to the very low area (less than two mm2) of the remaining tumor, 9 cases were excluded, leaving 157 for further analyses. The clinical and pathological data of these patients are summarized in Table 1.
+ Open protocol
+ Expand
3

Histological Analysis of Hepatocellular Carcinoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
A pathologist (RS) reviewed all archived slides to identify the most representative formalin-fixed paraffin-embedded (FFPE) block. The selected block includes non-necrotic HCC tissue, and, whenever possible (in 103 samples, accounting for 98.1% of the cases), the surrounding peritumoral liver parenchyma. The 3 µm sections were stained using a modified Gordon and Sweet’s silver impregnation protocol combined with Picric Acid–Sirius Red, referred to as GSPS (see Figure 2E–H, supplementary Table S1). This method is standard for liver and bone marrow samples at the National Center of Pathology. Throughout this paper, we define the red-staining fibers in the thick fibrous septae as ‘collagen’, and the delicate black linear strands mostly located in the epithelial areas as ‘reticulin’.
All slides were subsequently digitized at 20× magnification (0.5 μm per pixel) using an Aperio® AT2 DX scanner (Leica Aperio Technologies, Vista, CA, USA). A pathologist (RS) reviewed the images to mark the malignant (HCC) and non-malignant (peritumoral liver) areas on each slide by placing manual annotations (see Figure 3A,D). A HALO® AI (Indica Labs, Albuquerque, NM, USA) classifier was used to categorize the tissue into hepatocytes (indiscriminately malignant and non-malignant), stroma, and background classes.
+ Open protocol
+ Expand
4

AI-Powered Tissue Analysis Workflow

Check if the same lab product or an alternative is used in the 5 most similar protocols
We trained HALO® AI (Indica Labs, Albuquerque, NM, USA) Densenet v2 classifiers for the identification of artifacts, mainly due to co-agulation resulting from the TUR procedure, and to segment epithelium and stroma compartments. In CD20 WSI, we also trained a classifier to segment TLSs and exclude them from further CD20 quantification in the remaining tissue. For the detection of CD8, CD20, and ICOS-positive lymphocytes, we used the HALO® AI Multiplex IHC (Indica Labs, Albuquerque, NM, USA) module. Due to the irregularity of the cytoplasm in macrophages, the CD11c and CD163 macrophages were segmented by the HALO® Nuclei seg (Indica Labs, Albuquerque, NM, USA) classifier followed by the HALO® Nuclei Phenotyper (Indica Labs, Albuquerque, NM, USA) classifier.
+ Open protocol
+ Expand
5

Automated Quantification of Ki67 Density in BE

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to assess Ki67 density, the initial intent was to calculate the total number of BE epithelial Ki67+ cells divided by the total number of BE epithelial cells. Initial artificial intelligence (AI) algorithms resulted in undercounting of Ki67-negative cells based on visual inspection. Thus, the decision was made to estimate density as Ki67+ cells/mm2 BE epithelium. To do this, the immunostain for pan-cytokeratin was added to aid in detection of epithelial cells. Sections were stained with hematoxylin, and sequentially immunostained with Ki67 in brown (Ultraview DAB system/CC1 pretreatment solution; clone 30–9; Ventana Medical) and pan-cytokeratin in red (CK, Refine Red AP system/ER2 pretreatment solution; clone AE-1/3; Leica Biosystems). AI algorithms were developed using HALO-AI (v2.3.2089.30, Indica Labs) to classify tissues into CK-strong epithelium, CK-weak epithelium, stroma, and glass on the annotated images. Nuclear segmentation was performed and thresholds were determined for nuclear Ki67 positivity (nuclear counting algorithm). For each image, representative glands were manually counted and compared to the AI nuclear counting algorithms in order to optimize the algorithms within 5% error of manual count per image.
+ Open protocol
+ Expand
6

Deep Learning for Organoid Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Image analysis of the IF images was performed with HALO AI (Indica Labs, v.3.2.1851.328). Briefly, single organoids were automatically detected using a deep-learning algorithm trained to distinguish between matrix and organoids or tumouroids, (iterations: 11,415; cross-entropy: 0.428; DenseNet AI V2 Plugin). After quick validation, organoids and tumouroids were detected and labelled as individual ROIs, objects (Fig. 4c). Only objects >7,500 µm2 were considered positive.
+ Open protocol
+ Expand
7

Automated Tumor Epithelium Pathology

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pathology evaluation for laser-microdissected tumor epithelium was conducted by the study pathologist on H&E-stained slides, which were digitally imaged with an Aperio ScanScope AT scanner (Leica Microsystems, Wetzlar, Germany). HALO AI (Indica Labs, Albuquerque, NM) was used to classify and annotate the slides to guide LMD of tumor epithelium (Supplemental Materials and Methods).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!